CDC director nominee Erica Schwartz told the Senate health committee Wednesday that she will "never betray the science" [1].
The testimony comes as lawmakers seek guarantees that the nation's top public health agency will remain independent from political influence. This is particularly critical given the appointment of Health Secretary Robert F. Kennedy Jr., whose views on vaccines have sparked significant debate among medical professionals [2].
Schwartz, a former deputy surgeon general, appeared before the U.S. Senate Health, Education, Labor and Pensions Committee in Washington, D.C., on July 15, 2026 [1]. During the hearing, she said her leadership would be defined by "radical transparency" [3].
Senators pressed the nominee on whether she could resist specific policy pressures from the Health Secretary. One unnamed senator said, "We need to know you will stand up to political pressure" [4]. The exchange highlighted the tension between the administration's personnel choices and the established scientific consensus.
Reports on Schwartz's alignment with the administration vary. Some accounts suggest she backs the actions of Kennedy, while other reports indicate she faced intense questioning regarding her ability to resist his specific vaccine agenda [3, 5].
Schwartz said she is committed to restoring public trust in the agency. The nominee's ability to balance loyalty to the Trump administration with the objective requirements of public health data will be a primary focus of the confirmation process [2, 6].
“"I will never betray the science."”
The confirmation of Erica Schwartz represents a pivotal moment for the CDC's institutional autonomy. By pledging transparency and a commitment to science, Schwartz is attempting to bridge the gap between a skeptical scientific community and an administration led by Robert F. Kennedy Jr. The outcome of this hearing suggests that the Senate will prioritize the agency's independence as a prerequisite for maintaining public health stability.
